Monday, 16 April 2018

DCEP regimen buys time for multiple myeloma patients

Dr George Grigoriadis
The combination of dexamethasone, cyclophosphamide, etoposide, and cisplatin (DCEP) is an effective bridge to autologous stem cell transplant (ASCT) or novel agents in patients with relapsed refractory multiple myeloma.

Original story in The Limbic.

No comments:

Post a Comment